These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38939331)

  • 1. Corrigendum: Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy.
    Valvo VM; Vitale E; Tigano M; Evans R; Morgan MA; Zhang Q
    Front Oncol; 2024; 14():1424895. PubMed ID: 38939331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy.
    Valvo VM; Vitale E; Tigano M; Evans R; Morgan MA; Zhang Q
    Front Oncol; 2023; 13():1257622. PubMed ID: 37560464
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum: Antitumor effect and immune response of nanosecond pulsed electric fields in pancreatic cancer.
    Zhao J; Chen S; Zhu L; Zhang L; Liu J; Xu D; Tian G; Jiang T
    Front Oncol; 2022; 12():1052763. PubMed ID: 36303831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway.
    Wen X; Chen S; Chen X; Qiu H; Wang W; Zhang N; Liu W; Wang T; Ding X; Zhang L
    Front Oncol; 2024; 14():1381151. PubMed ID: 38463236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Microenvironment Cell Contribution to Lymphoma Immunity.
    Kumar D; Xu ML
    Front Oncol; 2018; 8():522. PubMed ID: 30460201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis.
    Du Y; Miao W; Jiang X; Cao J; Wang B; Wang Y; Yu J; Wang X; Liu H
    Front Oncol; 2023; 13():1185029. PubMed ID: 37251925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Targeting innate immunity in breast cancer therapy: a narrative review.
    Ye Y; Xu C; Chen F; Liu Q; Cheng N
    Front Immunol; 2023; 14():1353708. PubMed ID: 38179059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma.
    Liu H; Xu Y; Liang K; Liu R
    Front Oncol; 2021; 11():817747. PubMed ID: 35004334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Somatic DNA damage response and homologous repair gene alterations and its association with tumor variant burden in breast cancer patients with occupational exposure to pesticides.
    Scandolara TB; Valle SF; Esteves C; Scherer NM; de Armas EM; Furtado C; Gomes R; Boroni M; Jaques HDS; Alves FM; Rech D; Panis C; Bonvicino CR
    Front Oncol; 2022; 12():1014392. PubMed ID: 36212417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Lipid metabolism in tumor immunology and immunotherapy.
    Duong LK; Corbali HI; Riad TS; Ganjoo S; Nanez S; Voss T; Barsoumian HB; Welsh J; Cortez MA
    Front Oncol; 2023; 13():1358498. PubMed ID: 38260855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.
    Chan Wah Hak CML; Rullan A; Patin EC; Pedersen M; Melcher AA; Harrington KJ
    Front Oncol; 2022; 12():971959. PubMed ID: 36106115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Innate Immune Cells in the Esophageal Tumor Microenvironment.
    Cui K; Hu S; Mei X; Cheng M
    Front Immunol; 2021; 12():708705. PubMed ID: 34122459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma.
    Liu Y; Feng W; Dai Y; Bao M; Yuan Z; He M; Qin Z; Liao S; He J; Huang Q; Yu Z; Zeng Y; Guo B; Huang R; Yang R; Jiang Y; Liao J; Xiao Z; Zhan X; Lin C; Xu J; Ye Y; Ma J; Wei Q; Mo Z
    Front Oncol; 2022; 12():1077067. PubMed ID: 36457508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.
    Li B; Zhao X; Zhang L; Cheng W
    Front Oncol; 2021; 11():687841. PubMed ID: 34150656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
    Wilson JD; Hammond EM; Higgins GS; Petersson K
    Front Oncol; 2020; 10():210. PubMed ID: 32161721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.
    Zhang T; Nie Y; Gu J; Cai K; Chen X; Li H; Wang J
    Front Oncol; 2021; 11():843623. PubMed ID: 35111689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer.
    Ham WS; Park JS; Jang WS; Kim J
    Front Oncol; 2024; 14():1427226. PubMed ID: 38939340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
    Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
    J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Machine learning in non-small cell lung cancer radiotherapy: a bibliometric analysis.
    Zhang J; Zhu H; Wang J; Chen Y; Li Y; Chen X; Chen M; Cai Z; Liu W
    Front Oncol; 2023; 13():1197217. PubMed ID: 37143938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy.
    Titmarsh HF; O'Connor R; Dhaliwal K; Akram AR
    Front Oncol; 2020; 10():1516. PubMed ID: 32974185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.